Clinical Trial Update: Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on sequencing regorafenib and trifluridine/tipiracil in metastatic colorectal cancer; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)
• Stivarga (regorafenib)

Snippet

Sponsor: UNICANCER | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED